Lundbeck
HLUN-B.CO
#2582
Rank
ยฃ4.27 B
Marketcap
ยฃ4.49
Share price
-0.98%
Change (1 day)
19.78%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Revenue for Lundbeck (HLUN-B.CO)

Revenue in 2024 (TTM): ยฃ2.44 Billion

According to Lundbeck 's latest financial reports the company's current revenue (TTM ) is ยฃ2.50 Billion. In 2023 the company made a revenue of ยฃ2.27 Billion an increase over the revenue in the year 2022 that were of ยฃ2.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lundbeck from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ2.44 B7.51%
2023 ยฃ2.27 B6.58%
2022 ยฃ2.13 B12.96%
2021 ยฃ1.88 B-6.12%
2020 ยฃ2.01 B1.5%
2019 ยฃ1.98 B-10.79%
2018 ยฃ2.22 B12.85%
2017 ยฃ1.96 B4.82%
2016 ยฃ1.87 B28.74%
2015 ยฃ1.45 B-3.93%
2014 ยฃ1.51 B-7.57%
2013 ยฃ1.64 B2.66%
2012 ยฃ1.60 B-16.11%
2011 ยฃ1.90 B12.93%
2010 ยฃ1.69 B5.22%
2009 ยฃ1.60 B